AGC Bio to sell two sites in Colorado, will lay off 278 workers in the processnews2025-09-17T14:41:51+00:00September 17th, 2025|Endpoints News|
Monarez updates: Ousted CDC director testifies before Senate health committeenews2025-09-17T13:30:32+00:00September 17th, 2025|Endpoints News|
Lilly’s diabetes pill beats Novo’s Rybelsus in head-to-head trial, company mulls fast-track filingnews2025-09-17T13:00:43+00:00September 17th, 2025|Endpoints News|
AstraZeneca’s Fasenra once again falls short in COPDnews2025-09-17T11:09:23+00:00September 17th, 2025|Endpoints News|
GSK budgets $30B to boost US presencenews2025-09-16T23:01:44+00:00September 16th, 2025|Endpoints News|
#EASD25: Lilly unwraps more Phase 3 obesity pill data, but they still lag behind Novo’s oral Wegovynews2025-09-16T22:01:48+00:00September 16th, 2025|Endpoints News|
Drugmakers submit plans to join 340B rebate model pilot programnews2025-09-16T19:52:48+00:00September 16th, 2025|Endpoints News|
Pfizer, Novartis, BMS, Lilly and others targeted in FDA’s TV ad crackdownnews2025-09-16T19:27:05+00:00September 16th, 2025|Endpoints News|
Eli Lilly picks Virginia for $5B API site as part of $27B US pledgenews2025-09-16T14:30:17+00:00September 16th, 2025|Endpoints News|
Covid-19 vaccine makers sidelined ahead of upcoming ACIP meeting, sources saynews2025-09-15T21:22:10+00:00September 15th, 2025|Endpoints News|
